Previous 10 | Next 10 |
Buying shares of a fast-growing company only to see its stock nearly cut in half can bring a lot of tears. But investors can overcome short-term fears by taking a closer look at the business. If everything is on track with sales and profits, it's much easier to ignore the day-to-day or ...
Lately, the stock market has been on a wild ride, triggered by the rising yield curve and rotation of investors from growth stocks to value stocks. Correctly timing the market amid such high uncertainty is near impossible. But such times of uncertainty also present an opportunity -- to pick...
Fulgent Genetics (NASDAQ: FLGT) capped off 2020 with a mammoth fourth quarter. Revenue was up 3,400% thanks to the company's move into COVID-19 testing. In this video from Motley Fool Live , recorded on Mar ch 8 , Fool.com contributors Brian Orelli and Keith Spei...
Cathie Wood and her investment management firm, ARK Invest, have gained a dedicated following over the past few years. ARK has earned this attention through its publication of detailed predictions about several industries, as well as stellar investment performance. In fact, ARK's funds ha...
Over the past year, shares of Fulgent Genetics (NASDAQ: FLGT) have skyrocketed over 970%, reaching an all-time high of $189.89 on Feb. 7. Since then, however, the COVID-19 test manufacturer has seen its stock price plunge by almost 35%. What could possibly be behind such w...
These Biotech Stocks Are Red Hot Right Now. Biotech stocks continue to show promise to investors who bet on them. Could this be the right time to jump on the biotech bandwagon? Opportunities for overnight astronomical gains could happen when biotech companies report successful c...
Can These Top Health Care Stocks Keep Up Their Momentum This Week? The health care sector continues to play a critical role in the economy. This could mean well for investors who have invested in health care stocks . Despite the pandemic placing an enormous strain on the global ...
Fulgent Genetics (FLGT) announces that the U.S. Centers for Disease Control and Prevention (“CDC”) has awarded the company a contract to provide genomic sequencing of samples of SARS-CoV-2 on an ongoing basis, leveraging its Next Generation Sequencing (“NGS”) capab...
TEMPLE CITY, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its scalable platform, today announced that the U.S. Center...
Genetic testing is a hot market right now. But some of the companies involved in genetic testing have very different business models. In this Motley Fool Live video recorded on March 3, 2021 , Fool.com contributors Keith Speights and Brian Orelli address a viewer's question abo...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2024 financial results be...
2024-07-01 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...